INS and Insulin resistance: From a recent proteomics study in the same cohort of women (58), benign endometrial tissue in women with obesity and insulin resistance, which were considered to be “at-risk” of developing endometrial cancer, was found to have specific upregulation of proteins involved in insulin signaling and oncogenic signaling pathways.